Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ito

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Identification of a High-Frequency Somatic NLRC4 Mutation as a Cause of Autoinflammation by Pluripotent Cell-Based Phenotype DissectionYuri Kawasaki, Hirotsugu Oda, Jun Ito, et al.
Plant Physiology|March 21, 2012
Isolation and proteomic characterization of the Arabidopsis Golgi defines functional and novel components involved in plant cell wall biosynthesisHarriet T Parsons, Katy Christiansen, Bernhard Knierim, et al.
Nephron. Clinical Practice|May 24, 2008
Impact and perspective on chronic kidney disease in an Asian developing country: a large-scale survey in North VietnamJun Ito, Dinh Thi Kim Dung, Mai Tuyet Vuong, et al.
Journal of Asthma and Allergy|April 11, 2024
Usefulness of Computed Tomography for Evaluating the Effects of Bronchial Thermoplasty in Japanese Patients with Severe AsthmaSumiko Abe, Mina Yasuda, Kazunori Tobino, et al.
Journal of Gastroenterology|March 20, 2017
Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapyGoki Suda, Koji Ogawa, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 20, 2017
Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled studyGoki Suda, Jun Ito, Atsushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 21, 2016
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infectionJun Ito, Goki Suda, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 13, 2016
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairmentGoki Suda, Atsushi Nagasaka, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2018
Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunctionTakuya Sho, Goki Suda, Atsushi Nagasaka, et al.
Kidney International Reports|July 18, 2025
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2016
Identification of a High-Frequency Somatic NLRC4 Mutation as a Cause of Autoinflammation by Pluripotent Cell-Based Phenotype DissectionYuri Kawasaki, Hirotsugu Oda, Jun Ito, et al.
Plant Physiology|March 21, 2012
Isolation and proteomic characterization of the Arabidopsis Golgi defines functional and novel components involved in plant cell wall biosynthesisHarriet T Parsons, Katy Christiansen, Bernhard Knierim, et al.
Nephron. Clinical Practice|May 24, 2008
Impact and perspective on chronic kidney disease in an Asian developing country: a large-scale survey in North VietnamJun Ito, Dinh Thi Kim Dung, Mai Tuyet Vuong, et al.
Journal of Asthma and Allergy|April 11, 2024
Usefulness of Computed Tomography for Evaluating the Effects of Bronchial Thermoplasty in Japanese Patients with Severe AsthmaSumiko Abe, Mina Yasuda, Kazunori Tobino, et al.
Journal of Gastroenterology|March 20, 2017
Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapyGoki Suda, Koji Ogawa, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 20, 2017
Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled studyGoki Suda, Jun Ito, Atsushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 21, 2016
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infectionJun Ito, Goki Suda, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 13, 2016
Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairmentGoki Suda, Atsushi Nagasaka, Yoshiya Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2018
Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunctionTakuya Sho, Goki Suda, Atsushi Nagasaka, et al.
Kidney International Reports|July 18, 2025
Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1063-1075]Kiyotaka Uchiyama, Daisuke Kamano, Tomoki Nagasaka, et al.
Pageof 25